100 results on '"Medvecz, M."'
Search Results
2. 501 Comparison of the effectiveness of optically guided high-frequency ultrasound and multispectral imaging for the in vivo measurement of melanoma tumor thickness
- Author
-
Bozsányi, S., primary, Varga, N.N., additional, Farkas, K., additional, Hamilton-Meikle, P., additional, Bánvölgyi, A., additional, Lihacova, I., additional, Lihachev, A., additional, Lange, M., additional, Paragh, G., additional, Wikonkál, N.M., additional, Medvecz, M., additional, and Kiss, N., additional
- Published
- 2023
- Full Text
- View/download PDF
3. 456 Multispectral imaging algorithm predicts Breslow tumor depth of malignant melanoma
- Author
-
Bozsányi, S., primary, Varga, N.N., additional, Farkas, K., additional, Banvolgyi, A., additional, Lorincz, K., additional, Paragh, G., additional, Holló, P., additional, Medvecz, M., additional, Kiss, N., additional, and Wikonkál, N., additional
- Published
- 2022
- Full Text
- View/download PDF
4. 061 Immunohistochemical study of the PD-1/PD-L1 pathway in cutaneous lupus erythematosus
- Author
-
Király, Z., primary, Szepesi, Á., additional, Sebestyén, A., additional, Kuroli, E., additional, Rencz, F., additional, Tóth, B., additional, Bokor, L., additional, Szakonyi, J., additional, Medvecz, M., additional, and Hidvégi, B., additional
- Published
- 2022
- Full Text
- View/download PDF
5. 479 Introduction of a Novel Multispectral Imaging Screening Algorithm to Distinguish Malignant Melanoma from Seborrheic Keratosis
- Author
-
Bánvölgyi, A., primary, Bozsányi, S., additional, Farkas, K., additional, Lörincz, K., additional, Jobbágy, A., additional, Lihacova, I., additional, Lihachev, A., additional, Medvecz, M., additional, Kiss, N., additional, and Wikonkál, N.M., additional
- Published
- 2022
- Full Text
- View/download PDF
6. 381 Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals
- Author
-
Piros, É.A., primary, Cseprekál, O., additional, Lukács, A., additional, Hidvégi, B., additional, Medvecz, M., additional, Szabó, Z., additional, Barabás, E., additional, Galajda, N., additional, Miheller, P., additional, and Holló, P., additional
- Published
- 2022
- Full Text
- View/download PDF
7. 313 A case of familiar white sponge nevus with KRT4 gene variants
- Author
-
Mazan, M., primary, Medvecz, M., additional, Kuroli, E., additional, Karpati, S., additional, and Mayer, B., additional
- Published
- 2022
- Full Text
- View/download PDF
8. Proposal for a 6-step approach for differential diagnosis of neonatal erythroderma
- Author
-
Cuperus, E., Bygum, A., Boeckmann, L., Bodemer, C., Bolling, M. C., Caproni, M., Diociaiuti, A., Emmert, S., Fischer, J., Gostynski, A., Guez, S., van Gijn, M. E., Hannula-Jouppi, K., Has, C., Hernandez-Martin, A., Martinez, A. E., Mazereeuw-Hautier, J., Medvecz, M., Neri, I., Sigurdsson, V., Suessmuth, K., Traupe, H., Oji, V., Pasmans, S. G. M. A., Department of Dermatology, Allergology and Venereology, and HUS Inflammation Center
- Subjects
GAUCHER-DISEASE ,ICHTHYOSIFORM ERYTHRODERMA ,NETHERTON-SYNDROME ,3121 General medicine, internal medicine and other clinical medicine ,VERSUS-HOST-DISEASE ,OMENN SYNDROME ,AEC SYNDROME ,PRIMARY IMMUNODEFICIENCY DISORDERS ,CHANARIN-DORFMAN SYNDROME ,HAIR SAMPLES ,COLLODION BABY - Abstract
The broad differential diagnosis of neonatal erythroderma often poses a diagnostic challenge. Mortality of neonatal erythroderma is high due to complications of the erythroderma itself and the occasionally severe and life-threatening underlying disease. Early correct recognition of the underlying cause leads to better treatment and prognosis. Currently, neonatal erythroderma is approached on a case-by-case basis. The purpose of this scoping review was to develop a diagnostic approach in neonatal erythroderma. After a systematic literature search in Embase (January 1990 - May 2020, 74 cases of neonatal erythroderma were identified, and 50+ diagnoses could be extracted. Main causes were the ichthyoses (40%) and primary immunodeficiencies (35%). Congenital erythroderma was present in 64% (47/74) of the cases, predominantly with congenital ichthyosis (11/11; 100%), Netherton syndrome (12/14, 86%) and Omenn syndrome (11/23, 48%). Time until diagnosis ranged from 102 days to 116 days for cases of non-congenital erythroderma and congenital erythroderma respectively. Among the 74 identified cases a total of 17 patients (23%) died within a mean of 158 days and were related to Omenn syndrome (35%), graft-versus-host disease (67%) and Netherton syndrome (18%). Disease history and physical examination are summarized in this paper. Age of onset and a collodion membrane can help to narrow the differential diagnoses. Investigations of blood, histology, hair analysis, genetic analysis and clinical imaging are summarized and discussed. A standard blood investigation is proposed, and the need for skin biopsies with lympho-epithelial Kazal-type related Inhibitor staining is highlighted. Overall, this review shows that diagnostic procedures narrow the differential diagnosis in neonatal erythroderma. A 6-step flowchart for the diagnostic approach for neonatal erythroderma during the first month of life is proposed. The approach was made with the support of expert leaders from international multidisciplinary collaborations in the European Reference Network Skin-subthematic group Ichthyosis.
- Published
- 2022
9. Proposal for a 6-step approach for differential diagnosis of neonatal erythroderma
- Author
-
MS Dermatologie/Allergologie, Other research (not in main researchprogram), Cuperus, E., Bygum, A., Boeckmann, L., Bodemer, C., Bolling, M. C., Caproni, M., Diociaiuti, A., Emmert, S., Fischer, J., Gostynski, A., Guez, S., van Gijn, M. E., Hannulla-Jouppi, K., Has, C., Hernández-Martín, A., Martinez, A. E., Mazereeuw-Hautier, J., Medvecz, M., Neri, I., Sigurdsson, V., Suessmuth, K., Traupe, H., Oji, V., Pasmans, S. G.M.A., MS Dermatologie/Allergologie, Other research (not in main researchprogram), Cuperus, E., Bygum, A., Boeckmann, L., Bodemer, C., Bolling, M. C., Caproni, M., Diociaiuti, A., Emmert, S., Fischer, J., Gostynski, A., Guez, S., van Gijn, M. E., Hannulla-Jouppi, K., Has, C., Hernández-Martín, A., Martinez, A. E., Mazereeuw-Hautier, J., Medvecz, M., Neri, I., Sigurdsson, V., Suessmuth, K., Traupe, H., Oji, V., and Pasmans, S. G.M.A.
- Published
- 2022
10. Proposal for a 6‐step approach for differential diagnosis of neonatal erythroderma
- Author
-
Cuperus, E., primary, Bygum, A., additional, Boeckmann, L., additional, Bodemer, C., additional, Bolling, M.C., additional, Caproni, M., additional, Diociaiuti, A., additional, Emmert, S., additional, Fischer, J., additional, Gostynski, A., additional, Guez, S., additional, van Gijn, M.E., additional, Hannulla‐Jouppi, K., additional, Has, C., additional, Hernández‐Martín, A., additional, Martinez, A.E., additional, Mazereeuw‐Hautier, J., additional, Medvecz, M., additional, Neri, I., additional, Sigurdsson, V., additional, Suessmuth, K., additional, Traupe, H., additional, Oji, V., additional, and Pasmans, S.G.M.A., additional
- Published
- 2022
- Full Text
- View/download PDF
11. Low concentration Phloxine B staining for high chemical contrast, nonlinear microscope mosaic imaging of skin alterations in pseudoxanthoma elasticum
- Author
-
Fésűs, L., primary, Plázár, D., additional, Kolonics, A., additional, Martin, L., additional, Wikonkál, N., additional, Medvecz, M., additional, and Szipőcs, R., additional
- Published
- 2021
- Full Text
- View/download PDF
12. 089 Autofluorescence imaging for non-invasive visualization and quantification of skin lesions of patients with pseudoxanthoma elasticum
- Author
-
Farkas, K., primary, Bozsányi, S., additional, Fesus, L., additional, Lihacova, I., additional, Lihachev, A., additional, Lange, M., additional, Arányi, T., additional, Wikonkal, N., additional, Medvecz, M., additional, and Kiss, N., additional
- Published
- 2021
- Full Text
- View/download PDF
13. 068 Association of systemic involvement with skin morphology assessed by multiphoton microscopy in pseudoxanthoma elasticum
- Author
-
Fesus, L., primary, Kiss, N., additional, Navasiolava, N., additional, Plázár, D., additional, Farkas, K., additional, Zakariás, S., additional, Róbert, L., additional, Wikonkal, N., additional, Martin, L., additional, and Medvecz, M., additional
- Published
- 2021
- Full Text
- View/download PDF
14. 290 Nonlinear microscopy for the visualization of calcification and assessment of connective tissue fibers in pseudoxanthoma elasticum
- Author
-
Kiss, N., primary, Fesus, L., additional, Szeri, F., additional, Aranyi, T., additional, Van Gils, M., additional, Vanakker, O., additional, Martin, L., additional, Szipocs, R., additional, Wikonkal, N., additional, and Medvecz, M., additional
- Published
- 2019
- Full Text
- View/download PDF
15. Lymphoproliferative diseases among patients treated with biologicals: a case study and single center survey
- Author
-
Szakonyi, J., primary, Medvecz, M., additional, Wikonkál, N., additional, Holló, P., additional, Hídvégi, B., additional, Demeter, J., additional, Csomor, J., additional, Szepesi, Á., additional, and Marschalkó, M., additional
- Published
- 2019
- Full Text
- View/download PDF
16. Low concentration Phloxine B staining for high chemical contrast, nonlinear microscope mosaic imaging of skin alterations in pseudoxanthoma elasticum
- Author
-
Fésűs, L., Plázár, D., Kolonics, A., Martin, L., Wikonkál, N., Medvecz, M., and Szipőcs, R.
- Abstract
Pseudoxanthoma elasticum (PXE) is an autosomal recessive metabolic disorder characterized by ectopic mineralization of soft connective tissue. Histopathology findings include fragmented, mineralized elastic fibers and calcium deposits in the mid-dermis. Nonlinear microscopy (NLM) can be used for visualization of these histopathological alterations of the mid-dermis in PXE-affected skin sections. Upon introducing a normalized 3D color vector representation of emission spectra of three of the main tissue components (collagen, elastin and calcification) we found that due to their broad, overlapping emission spectra, spectral separation of emission from elastin and calcification is practically impossible in fresh-frozen or unstained, deparaffinized PXE sections. However, we found that the application of a low concentration Phloxine B staining after the deparaffinization process creates an imaging contrast for these two tissue components, which enables spectral decomposition of their fluorescence images. The obtained concentration maps for calcium deposits can be well suited for the determination of illness severity by quantitative analysis.
- Published
- 2022
17. Alitretinoin in punctate palmoplantar keratoderma
- Author
-
Yilmaz, P., primary, Medvecz, M., additional, Kohlhase, J., additional, Küsel, J., additional, Fischer, J., additional, and Has, C., additional
- Published
- 2018
- Full Text
- View/download PDF
18. Low concentration Phloxine B staining for high chemical contrast, nonlinear microscope mosaic imaging of skin alterations in pseudoxanthoma elasticum
- Author
-
Beaurepaire, Emmanuel, Ben-Yakar, Adela, Park, YongKeun, Fésűs, L., Martin, L., Wikonkál, N., Medvecz, M., and Szipőcs, R.
- Published
- 2021
- Full Text
- View/download PDF
19. Confirmation of the role of aKRT5mutation and successful management of skin lesions in a patient with Galli-Galli disease
- Author
-
Lőrincz, K., primary, Medvecz, M., additional, Kiss, N., additional, Glász-Bóna, A., additional, Hársing, J., additional, Lepesi-Benkő, R., additional, Hatvani, Z., additional, Mazán, M., additional, Kárpáti, S., additional, and Wikonkál, N., additional
- Published
- 2018
- Full Text
- View/download PDF
20. 760 Ex-vivo nonlinear microscopy imaging of Ehlers-Danlos syndrome-affected skin
- Author
-
Lrincz, K., primary, Kiss, N., additional, Haluszka, D., additional, Kuroli, E., additional, Hársing, J., additional, Mayer, B., additional, Kárpáti, S., additional, Fekete, G., additional, Szipcs, R., additional, Wikonkál, N., additional, and Medvecz, M., additional
- Published
- 2018
- Full Text
- View/download PDF
21. 235 Genotype-phenotype correlation in vascular Ehlers-Danlos syndrome: Novel duplication mutation of COL3A1 gene in a large pedigree
- Author
-
Medvecz, M., primary, Fekete, G., additional, Mayer, B., additional, and Kárpáti, S., additional
- Published
- 2017
- Full Text
- View/download PDF
22. 239 Investigation of the genetic background of Hungarian patients with nevoid basal-cell carcinoma syndrome
- Author
-
Marton, D., primary, Kiss, N., additional, Lorincz, K., additional, Banvolgyi, A., additional, Gyongyosi, N., additional, Medvecz, M., additional, and Wikonkal, N.M., additional
- Published
- 2017
- Full Text
- View/download PDF
23. A uniqueLAMB3splice-site mutation with founder effect from the Balkans causes lethal epidermolysis bullosa in several European countries
- Author
-
Mayer, B., primary, Silló, P., additional, Mazán, M., additional, Pintér, D., additional, Medvecz, M., additional, Has, C., additional, Castiglia, D., additional, Petit, F., additional, Charlesworth, A., additional, Hatvani, Zs., additional, Pamjav, H., additional, and Kárpáti, S., additional
- Published
- 2016
- Full Text
- View/download PDF
24. LB1721 A novel pathogenic TPCN2mutation detected for the first time in a Caucasian patient confirms the dominant inheritance of albinism
- Author
-
Nagy, N., Pal, M., Kun, J., Bence, G., Urban, P., Medvecz, M., Fábos, B., Neller, A., Danis, J., Hammad, Z., AlMarsomy, S., Adam, E., Gyenesei, A., and Szell, M.
- Published
- 2023
- Full Text
- View/download PDF
25. Confirmation of the role of a KRT5 mutation and successful management of skin lesions in a patient with Galli–Galli disease.
- Author
-
Lőrincz, K., Medvecz, M., Kiss, N., Glász‐Bóna, A., Hársing, J., Lepesi‐Benkő, R., Hatvani, Z., Mazán, M., Kárpáti, S., and Wikonkál, N.
- Subjects
- *
TISSUE wounds , *HYPERPIGMENTATION , *GENETIC mutation , *EPIDERMIS , *SKIN diseases - Abstract
Click here for the corresponding questions to this CME article. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
26. 501 Comparison of the effectiveness of optically guided high-frequency ultrasound and multispectral imaging for the in vivomeasurement of melanoma tumor thickness
- Author
-
Bozsányi, S., Varga, N.N., Farkas, K., Hamilton-Meikle, P., Bánvölgyi, A., Lihacova, I., Lihachev, A., Lange, M., Paragh, G., Wikonkál, N.M., Medvecz, M., and Kiss, N.
- Published
- 2023
- Full Text
- View/download PDF
27. A unique LAMB3 splice-site mutation with founder effect from the Balkans causes lethal epidermolysis bullosa in several European countries.
- Author
-
Mayer, B., Silló, P., Mazán, M., Pintér, D., Medvecz, M., Has, C., Castiglia, D., Petit, F., Charlesworth, A., Hatvani, Zs., Pamjav, H., and Kárpáti, S.
- Subjects
LAMININS ,EPIDERMOLYSIS bullosa ,INFANT diseases ,ANTISENSE DNA ,DNA mutational analysis ,POPULATION - Abstract
Background We have encountered repeated cases of recessive lethal generalized severe (Herlitz-type) junctional epidermolysis bullosa ( JEB gen sev) in infants born to Hungarian Roma parents residing in a small region of Hungary. Objectives To identify the disease-causing mutation and to investigate the genetic background of its unique carrier group. Methods The LAMB3 gene was analysed in peripheral-blood genomic DNA samples, and the pathological consequences of the lethal defect were confirmed by cutaneous LAMB3 cDNA sequencing. A median joining haplotype network within the Y chromosome H1a-M82 haplogroup of individuals from the community was constructed, and LAMB3 single-nucleotide polymorphism ( SNP) patterns were also determined. Results An unconventional intronic splice-site mutation ( LAMB3, c.1133-22G>A) was identified. Thirty of 64 voluntarily screened Roma from the closed community carried the mutation, but none of the 306 Roma from other regions of the country did. The age of the mutation was estimated to be 548 ± 222 years. Within the last year, more patients with JEB gen sev carrying the same unusual mutation have been identified in three unrelated families, all immigrants from the Balkans. Two were compound heterozygous newborns, in Germany and Italy, and one homozygous newborn died in France. Only the French family recognized their Roma background. LAMB3 SNP haplotyping confirmed the link between the apparently unrelated Hungarian, German and Italian male cases, but could not verify the same background in the female newborn from France. Conclusions The estimated age of the mutation corresponds to the time period when Roma were wandering in the Balkans. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
28. Low concentration Phloxine B staining for high chemical contrast, nonlinear microscope mosaic imaging of skin alterations in pseudoxanthoma elasticum.
- Author
-
Fésűs, L., Martin, L., Wikonkál, N., Medvecz, M., and Szipőcs, R.
- Published
- 2021
- Full Text
- View/download PDF
29. Alitretinoin in punctate palmoplantar keratoderma.
- Author
-
Yilmaz, P., Medvecz, M., Kohlhase, J., Küsel, J., Fischer, J., and Has, C.
- Subjects
- *
PALMOPLANTAR keratoderma , *PATIENT participation - Abstract
The article presents a study that determines the conditions and symptoms of palmoplantar keratoderma punctata type 1 (PPKP1). It offers details of the method of the study that observes 13 patients who had typical PPKP1 features. It outlines the result and suggests the importance of long-term maintenance as mandatory to prevent reaggravation.
- Published
- 2019
- Full Text
- View/download PDF
30. Multiple bronchial carcinoids associated with Cowden syndrome.
- Author
-
Tömböl Z, Tőke J, Tóth G, Varga Z, Balázs E, Tóth E, Gergely L, Danihel Ľ, Medvecz M, Borka K, and Tóth M
- Subjects
- Humans, Middle Aged, Male, Bronchial Neoplasms genetics, Bronchial Neoplasms diagnostic imaging, Bronchial Neoplasms complications, Bronchial Neoplasms pathology, Bronchial Neoplasms diagnosis, PTEN Phosphohydrolase genetics, Hamartoma Syndrome, Multiple genetics, Hamartoma Syndrome, Multiple complications, Hamartoma Syndrome, Multiple pathology, Hamartoma Syndrome, Multiple diagnosis, Carcinoid Tumor complications, Carcinoid Tumor genetics, Carcinoid Tumor pathology, Carcinoid Tumor diagnosis
- Abstract
Cowden syndrome (CS) is a rare genetic condition due to the various germline mutations in the phosphatase and tensin homologue on chromosome ten (PTEN) tumour suppressor gene. As a result, CS is characterised by an increased risk of developing various benign and malignant tumours, such as thyroid, breast, endometrial and urogenital neoplasms, as well as gastrointestinal tract tumours. However, the neuroendocrine tumour association with CS is not elucidated yet. We present a case of a 46-year-old male patient diagnosed with testicular seminoma and follicular thyroid cancer in his medical history. Our patient met the clinical diagnostic criteria of Cowden syndrome. Genetic analysis established the clinical diagnosis; a known heterozygous PTEN mutation was detected [PTEN (LRG_311t1)c.388 C > T (p.Arg130Ter)]. Incidentally, he was also seen with multiple pulmonary lesions during his oncological follow-up. A video-assisted thoracoscopic left lingula wedge resection and later resections from the right lung were performed. Histological findings revealed typical pulmonary carcinoid tumours and smaller tumorlets. Somatostatin receptor SPECT-CT,
18 F-FDG-PET-CT and18 F-FDOPA-PET-CT scans and endoscopy procedures could not identify any primary tumours in other locations. Our patient is the first published case of Cowden syndrome, associated with multifocal pulmonary carcinoids. Besides multiple endocrine neoplasia type 1, we propose Cowden syndrome as another hereditary condition predisposing to multiple pulmonary tumorlets and carcinoid tumours., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
31. Missing Heritability in Albinism: Deep Characterization of a Hungarian Albinism Cohort Raises the Possibility of the Digenic Genetic Background of the Disease.
- Author
-
Nagy N, Pal M, Kun J, Galik B, Urban P, Medvecz M, Fabos B, Neller A, Abdolreza A, Danis J, Szabo V, Yang Z, Fenske S, Biel M, Gyenesei A, Adam E, and Szell M
- Subjects
- Humans, Male, Adolescent, Hungary, Mutation, Genetic Background, Membrane Transport Proteins metabolism, Albinism genetics
- Abstract
Albinism is characterized by a variable degree of hypopigmentation affecting the skin and the hair, and causing ophthalmologic abnormalities. Its oculocutaneous, ocular and syndromic forms follow an autosomal or X-linked recessive mode of inheritance, and 22 disease-causing genes are implicated in their development. Our aim was to clarify the genetic background of a Hungarian albinism cohort. Using a 22-gene albinism panel, the genetic background of 11 of the 17 Hungarian patients was elucidated. In patients with unidentified genetic backgrounds ( n = 6), whole exome sequencing was performed. Our investigations revealed a novel, previously unreported rare variant (N687S) of the two-pore channel two gene ( TPCN2 ). The N687S variant of the encoded TPC2 protein is carried by a 15-year-old Hungarian male albinism patient and his clinically unaffected mother. Our segregational analysis and in vitro functional experiments suggest that the detected novel rare TPCN2 variant alone is not a disease-causing variant in albinism. Deep genetic analyses of the family revealed that the patient also carries a phenotype-modifying R305W variant of the OCA2 protein, and he is the only family member harboring this genotype. Our results raise the possibility that this digenic combination might contribute to the observed differences between the patient and the mother, and found the genetic background of the disease in his case.
- Published
- 2024
- Full Text
- View/download PDF
32. Optically Guided High-Frequency Ultrasound Shows Superior Efficacy for Preoperative Estimation of Breslow Thickness in Comparison with Multispectral Imaging: A Single-Center Prospective Validation Study.
- Author
-
Varga NN, Boostani M, Farkas K, Bánvölgyi A, Lőrincz K, Posta M, Lihacova I, Lihachev A, Medvecz M, Holló P, Paragh G, Wikonkál NM, Bozsányi S, and Kiss N
- Abstract
Melanoma is the most aggressive form of skin cancer that is known for its metastatic potential and has an increasing incidence worldwide. Breslow thickness, which determines the staging and surgical margin of the tumor, is unavailable at initial diagnosis. Novel imaging techniques for assessing Breslow thickness lack comparative data. This study evaluates optically guided high-frequency ultrasound (OG-HFUS) and multispectral imaging (MSI) for preoperative estimation of Breslow thickness and staging. We enrolled 101 patients with histologically confirmed primary melanoma and categorized them based on tumor thickness. Optically guided 33 MHz HFUS and MSI were utilized for the assessment. Our MSI-based algorithm categorized melanomas into three subgroups with a sensitivity of 62.6%, specificity of 81.3%, and fair agreement (κ = 0.440, CI: 0.298-0.583). In contrast, OG-HFUS demonstrated a sensitivity of 91.8%, specificity of 96.0%, and almost perfect agreement (κ = 0.858, CI: 0.763-0.952). OG-HFUS performed better than MSI in estimating Breslow thickness, emphasizing its potential as a valuable tool for melanoma diagnosis and patient management. OG-HFUS holds promise for enhancing preoperative staging and treatment decision-making in melanoma.
- Published
- 2023
- Full Text
- View/download PDF
33. Primary Localized Cutaneous Amyloidosis in Central Europe: A Retrospective Monocentric Study on Epidemiology and Therapy.
- Author
-
Pálla S, Kuroli E, Tóth EA, Hidvégi B, Holló P, and Medvecz M
- Abstract
Amyloid deposits can be the cause of many chronic diseases. Primary localized cutaneous amyloidosis (PLCA) is a chronic dermatologic condition with amyloid deposits in the papillary dermis. The most common types of the keratinocyte-derived form of PLCA include macular (MA), lichen (LA), and biphasic (BA) amyloidosis. The estimated prevalence of PLCA in the Asian population is 0.98/10,000, which is higher than in the European population; thus, epidemiologic data on PLCA in the Caucasian population are limited. We performed a retrospective single-center study analyzing epidemiologic characteristics of a Central European PLCA population. Epidemiologic data regarding age, sex, skin phototype (Fitzpatrick scale I-VI), disease duration, comorbidities, history of atopy, and family history of PLCA were collected. Clinical characteristics, localization of PLCA lesions, applied therapies and treatment outcomes were also analyzed. Dermoscopic characteristics were also evaluated. A total of 41 patients diagnosed with PLCA were included, with 22 presenting with macular, 18 with lichen, and 1 with biphasic amyloidosis. The male/female ratio was 16/25, and mean age at diagnosis was 54.6 ± 15.2 years (range 27-87 years). The mean age at the onset of PLCA was 53 ± 16.1 years (range 19-79 years) in MA, 46.7 ± 18.2 years (range 14-73 years) in LA, and 26 years in BA. The interscapular region in MA and the extensor surface of the lower extremities in LA proved to be localization-related areas. In our center, a wide range of therapeutic options was applied, with the most prescribed being topical corticosteroids in all types of PLCA. We presented a retrospective, monocentric study on the epidemiology of PLCA in the Central European region. By examining the medical data of a significant number of PLCA patients, we compared our epidemiologic data with that of the Asian PLCA population. Due to the rarity of the condition, further randomized controlled trials and guidelines are needed to improve therapeutic outcomes.
- Published
- 2023
- Full Text
- View/download PDF
34. Multispectral Imaging Analysis of Skin Lesions in Patients with Neurofibromatosis Type 1.
- Author
-
Plorina EV, Saulus K, Rudzitis A, Kiss N, Medvecz M, Linova T, Bliznuks D, Lihachev A, and Lihacova I
- Abstract
Neurofibromatosis type 1 (NF1) is a rare disease, affecting around 1 in 3500 individuals in the general population. The rarity of the disease contributes to the scarcity of the available diagnostic and therapeutic approaches. Multispectral imaging is a non-invasive imaging method that shows promise in the diagnosis of various skin diseases. The device utilized for the present study consisted of four sets of narrow-band LEDs, including 526 nm, 663 nm, and 964 nm for diffuse reflectance imaging and 405 nm LEDs, filtered through a 515 nm long-pass filter, for autofluorescence imaging. RGB images were captured using a CMOS camera inside of the device. This paper presents the results of this multispectral skin imaging approach to distinguish the lesions in patients with NF1 from other more common benign skin lesions. The results show that the method provides a potential novel approach to distinguish NF1 lesions from other benign skin lesions.
- Published
- 2023
- Full Text
- View/download PDF
35. Dermoscopic Patterns of Genodermatoses: A Comprehensive Analysis.
- Author
-
Plázár D, Meznerics FA, Pálla S, Anker P, Farkas K, Bánvölgyi A, Kiss N, and Medvecz M
- Abstract
(1) Background: Genodermatoses are a clinically and genetically heterogenous group of inherited skin disorders. Diagnosing inherited skin diseases is a challenging task due to their rarity and diversity. Dermoscopy is a non-invasive, easily accessible, and rapid tool used in dermatology not only for diagnostic processes but also for monitoring therapeutic responses. Standardized terminologies have been published for its proper use, reproducibility, and comparability of dermoscopic terms. (2) Methods: Here, we aimed to investigate dermoscopic features in various genodermatoses by conducting a systematic review and comparing its results to our own findings, data of patients diagnosed with genodermatoses at the Department of Dermatology, Venereology and Dermatooncology, Semmelweis University. (3) Results: Our systematic search provided a total of 471 articles, of which 83 reported both descriptive and metaphoric dermoscopic terminologies of 14 genodermatoses. The literature data were then compared to the data of 119 patients with 14 genodermatoses diagnosed in our department. (4) Conclusion: Dermoscopy is a valuable tool in the diagnosis of genodermatoses, especially when symptoms are mild. To enable the use of dermoscopy as an auxiliary diagnostic method, existing standardized terminologies should be extended to more genodermatoses.
- Published
- 2023
- Full Text
- View/download PDF
36. Publisher Correction: Whole genome sequencing resolves 10 years diagnostic odyssey in familiar myxoma.
- Author
-
Pálla S, Tőke J, Bozsik A, Butz H, Papp J, Likó I, Kuroli E, Bánvölgyi A, Hamar M, Bertherat J, Medvecz M, and Patócs A
- Published
- 2023
- Full Text
- View/download PDF
37. Whole genome sequencing resolves 10 years diagnostic odyssey in familiar myxoma.
- Author
-
Pálla S, Tőke J, Bozsik A, Butz H, Papp J, Likó I, Kuroli E, Bánvölgyi A, Hamar M, Bertherat J, Medvecz M, and Patócs A
- Subjects
- Myxoma genetics, Humans, Gene Deletion, Pedigree, Promoter Regions, Genetic, Male, Female, Whole Genome Sequencing, Carney Complex diagnosis, Carney Complex genetics, Cyclic AMP-Dependent Protein Kinase RIalpha Subunit genetics
- Abstract
Carney complex (CNC) is an ultrarare disorder causing cutaneous and cardiac myxomas, primary pigmented nodular adrenocortical disease, hypophyseal adenoma, and gonadal tumours. Genetic alterations are often missed under routine genetic testing. Pathogenic variants in PRKAR1A are identified in most cases, while large exonic or chromosomal deletions have only been reported in a few cases. Our aim was to identify the causal genetic alteration in our kindred with a clinical diagnosis of CNC and prove its pathogenic role by functional investigation. Targeted testing of PRKAR1A gene, whole exome and whole genome sequencing (WGS) were performed in the proband, one clinically affected and one unaffected relative. WGS identified a novel, large, 10,662 bp (10.6 kbp; LRG_514t1:c.-10403_-7 + 265del; hg19, chr17:g.66498293_66508954del) deletion in the promoter of PRKAR1A in heterozygous form in the affected family members. The exact breakpoints and the increased enzyme activity in deletion carriers compared to wild type carrier were proved. Segregation analysis and functional evaluation of PKA activity confirmed the pathogenic role of this alteration. A novel deletion upstream of the PRKAR1A gene was proved to be the cause of CNC. Our study underlines the need for WGS in molecular genetic testing of patients with monogenic disorders where conventional genetic analysis fails., (© 2023. Springer Nature Limited.)
- Published
- 2023
- Full Text
- View/download PDF
38. Correlation of systemic involvement and presence of pathological skin calcification assessed by ex vivo nonlinear microscopy in Pseudoxanthoma elasticum.
- Author
-
Fésűs L, Kiss N, Farkas K, Plázár D, Pálla S, Navasiolava N, Róbert L, Wikonkál NM, Martin L, and Medvecz M
- Subjects
- Humans, Calcification, Physiologic, Mutation genetics, Elastin, Retrospective Studies, Male, Female, Adult, Middle Aged, Aged, Pseudoxanthoma Elasticum diagnosis, Pseudoxanthoma Elasticum genetics, Pseudoxanthoma Elasticum pathology, Connective Tissue pathology, Skin pathology
- Abstract
Pseudoxanthoma elasticum (PXE (OMIM 264800)) is an autosomal recessive connective tissue disorder mainly caused by mutations in the ABCC6 gene. PXE results in ectopic calcification primarily in the skin, eye and blood vessels that can lead to blindness, peripheral arterial disease and stroke. Previous studies found correlation between macroscopic skin involvement and severe ophthalmological and cardiovascular complications. This study aimed to investigate correlation between skin calcification and systemic involvement in PXE. Ex vivo nonlinear microscopy (NLM) imaging was performed on formalin fixed, deparaffinized, unstained skin sections to assess the extent of skin calcification. The area affected by calcification (CA) in the dermis and density of calcification (CD) was calculated. From CA and CD, calcification score (CS) was determined. The number of affected typical and nontypical skin sites were counted. Phenodex + scores were determined. The relationship between the ophthalmological, cerebro- and cardiovascular and other systemic complications and CA, CD and CS, respectively, and skin involvement were analyzed. Regression models were built for adjustment to age and sex. We found significant correlation of CA with the number of affected typical skin sites (r = 0.48), the Phenodex + score (r = 0.435), extent of vessel involvement (V-score) (r = 0.434) and disease duration (r = 0.48). CD correlated significantly with V-score (r = 0.539). CA was significantly higher in patients with more severe eye (p = 0.04) and vascular (p = 0.005) complications. We found significantly higher CD in patients with higher V-score (p = 0.018), and with internal carotid artery hypoplasia (p = 0.045). Significant correlation was found between higher CA and the presence of macula atrophy (β = - 0.44, p = 0.032) and acneiform skin changes (β = 0.40, p = 0.047). Based on our results, the assessment of skin calcification pattern with nonlinear microscopy in PXE may be useful for clinicians to identify PXE patients who develop severe systemic complications., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
39. Superimposed Mosaicism in the Form of Extremely Extended Segmental Plexiform Neurofibroma Caused by a Novel Pathogenic Variant in the NF1 Gene.
- Author
-
Veres K, Bene J, Hadzsiev K, Garami M, Pálla S, Happle R, Medvecz M, and Szalai ZZ
- Subjects
- Female, Humans, Child, Genes, Neurofibromatosis 1, Mosaicism, Mutation, Neurofibroma, Plexiform genetics, Neurofibromatosis 1 genetics
- Abstract
Plexiform neurofibromas occurring in approximately 20-50% of all neurofibromatosis type-1 (NF1) cases are histologically benign tumors, but they can be fatal due to compression of vital structures or transformation to malignant sarcomas or malignant peripheral nerve sheath tumors. All sizeable plexiform neurofibromas are thought to result from an early second mutation giving rise to a loss of heterozygosity of the NF1 gene. In this unusual case, a 12-year-old girl presented with a rapidly growing, extremely extensive plexiform neurofibroma with segmental distribution over the entire right arm, extending to the right chest wall and mediastinum, superimposed on classic cutaneous lesions of NF1. After several surgical interventions, the patient was efficiently treated with an oral selective MEK inhibitor, selumetinib, which resulted in a rapid reduction of the tumor volume. Molecular analysis of the NF1 gene revealed a c.2326-2 A>G splice-site mutation in the clinically unaffected skin, peripheral blood sample, and plexiform neurofibroma, which explains the general clinical symptoms. Furthermore, a novel likely pathogenic variant, c.4933dupC (p.Leu1645Profs*7), has been identified exclusively in the girl's plexiform neurofibromas. This second-hit mutation can explain the extremely extensive segmental involvement.
- Published
- 2023
- Full Text
- View/download PDF
40. A Cross-Sectional Study of the Dermatological Manifestations of Patients with Fabry Disease and the Assessment of Angiokeratomas with Multimodal Imaging.
- Author
-
Anker P, Fésűs L, Kiss N, Lengyel A, Pinti É, Lihacova I, Lihachev A, Plorina EV, Fekete G, and Medvecz M
- Abstract
Fabry disease (FD) is a multisystemic X-linked lysosomal storage disease that presents with angiokeratomas (AKs). Our objective was to investigate the clinical and morphologic features of AKs and to present two experimental techniques, multispectral imaging (MSI) and non-linear microscopy (NLM). A thorough dermatological examination was carried out in our 26 FD patients and dermoscopic images ( n = 136) were evaluated for specific structures. MSI was used for the evaluation of AKs in seven patients. NLM was carried out to obtain histology samples of two AKs and two hemangiomas. Although AKs were the most common manifestation, the majority of patients presented an atypical distribution and appearance, which could cause a diagnostic challenge. Dermoscopy revealed lacunae (65%) and dotted vessels (56%) as the most common structures, with a whitish veil present in only 25%. Autofluorescence (405 nm) and diffuse reflectance (526 nm) images showed the underlying vasculature more prominently compared to dermoscopy. Using NLM, AKs and hemangiomas could be distinguished based on morphologic features. The clinical heterogeneity of FD can result in a diagnostic delay. Although AKs are often the first sign of FD, their presentation is diverse. A thorough dermatological examination and the evaluation of other cutaneous signs are essential for the early diagnosis of FD.
- Published
- 2023
- Full Text
- View/download PDF
41. Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study.
- Author
-
Koszorú K, Kovács A, Lőrincz K, Medvecz M, and Sárdy M
- Subjects
- Humans, Glucocorticoids therapeutic use, Retrospective Studies, Methylprednisolone, Lichen Planus, Oral diagnosis, Lichen Planus, Oral drug therapy, Lichen Planus drug therapy
- Abstract
Background There are various topical and systemic treatment options for the management of lichen planus. However, it is often difficult to achieve long-term disease control and many of the common therapies may be associated with unwanted side effects. Aims To evaluate the effectiveness of 8 mg oral methylprednisolone administered daily in lichen planus by the analysis of medical records. Methods In this retrospective cohort study, we compared the rates of improvement between two groups of patients. The first group received 8 mg oral methylprednisolone daily for at least one month. In the second group, patients with similar parameters to the first group (age, sex, disease manifestation) but without systemic glucocorticoid therapy were included. Fisher's exact test was used to compare the rates of remission in the two groups. Results In the daily oral methylprednisolone (n = 24) and no systemic corticosteroids (n = 16) groups, 23 (95.8%) and 6 (37.5%) patients achieved partial or complete remission, respectively. The frequency of improvement was significantly higher in patients who received oral methylprednisolone (P < 0.0001). Limitations Limitations of this study include its retrospective design and the relatively small sample size. Conclusion Low dose oral glucocorticoid therapy may be an effective option for the systemic treatment of lichen planus. Based on our results and previous studies, instead of higher doses, longer therapy duration with low doses should be considered.
- Published
- 2023
- Full Text
- View/download PDF
42. [Dermoscopy of genodermatoses].
- Author
-
Plázár D, Joura MI, Kiss N, and Medvecz M
- Subjects
- Humans, Dermoscopy methods, Skin diagnostic imaging, Ichthyosis, Keratosis drug therapy, Pemphigus, Benign Familial
- Abstract
Genodermatoses are a group of inherited skin diseases whose diagnosis is challenging due to their rarity as well as their clinical and genetic diversity. The majority of genodermatoses are autosomal or X‑linked inherited, but mosaic forms are also observed. Genodermatoses comprise various phenotypes ranging from limited cutaneous disease to severe cutaneous and extracutaneous involvement and may also be early warning signs of a multisystemic disorder. Despite recent advances in genetic technology and skin imaging modalities, dermoscopy can be useful for screening, diagnosis, and treatment follow-up. In ectopic mineralization and lysosomal storage disorders (pseudoxanthoma elasticum and Fabry disease, respectively), cutaneous manifestations may indicate involvement of other organs. In keratinization diseases (e.g., ichthyoses) and acantholytic skin fragility disorders (e.g., Darier and Hailey-Hailey disease), dermoscopy may help to assess treatment response by visualizing background erythema, hyperkeratosis, and interkeratinocyte space prominence. Dermoscopy is a noninvasive, easily accessible, useful, in vivo assessment tool that is well established in dermatology to recognize characteristic features of genodermatoses., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
43. Co-occurrence of neurofibromatosis type 1 and pseudoachondroplasia - a first case report.
- Author
-
Pálla S, Anker P, Farkas K, Plázár D, Kiss S, Marschalkó P, Szalai Z, Bene J, Hadzsiev K, Maróti Z, Kalmár T, and Medvecz M
- Subjects
- Humans, Female, Mutation, Phenotype, Neurofibromatosis 1 complications, Neurofibromatosis 1 diagnosis, Neurofibromatosis 1 genetics, Achondroplasia diagnosis, Achondroplasia genetics
- Abstract
Background: Neurofibromatosis type 1 and pseudoachondroplasia are both rare autosomal dominant disorders, caused by pathogenic mutations in NF1 and COMP genes, respectively. Both neurofibromin 1 and cartilage oligomeric matrix protein (COMP) play a role in the development of the skeleton. Carrying both germline mutations has not been previously reported; however, it can affect the developing phenotype., Case Presentation: The index patient, an 8-year-old female presented with several skeletal and dermatologic anomalies resembling the coexistence of multiple syndromes. Her mother had dermatologic symptoms characteristic for neurofibromatosis type 1, and her father presented with distinct skeletal anomalies. NGS-based analysis revealed a heterozygous pathogenic mutation in genes NF1 and COMP in the index patient. A previously unreported heterozygous variant was detected for the NF1 gene. The sequencing of the COMP gene revealed a previously reported, pathogenic heterozygous variant that is responsible for the development of the pseudoachondroplasia phenotype., Conclusions: Here, we present the case of a young female carrying pathogenic NF1 and COMP mutations, diagnosed with two distinct heritable disorders, neurofibromatosis type 1 and pseudoachondroplasia. The coincidence of two monogenic autosomal dominant disorders is rare and can pose a differential diagnostic challenge. To the best of our knowledge, this is the first reported co-occurrence of these syndromes., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
44. [Characteristics of the course of lupus erythematosus panniculitis in a retrospective analysis of 17 patients].
- Author
-
Király Z, Kovács A, Medvecz M, Róbert L, Bokor L, Kuroli E, Szepesi Á, Marschalkó M, and Hidvégi B
- Subjects
- Humans, Male, Female, Adult, Retrospective Studies, Quality of Life, Panniculitis, Lupus Erythematosus diagnosis, Panniculitis, Lupus Erythematosus pathology, Panniculitis diagnosis, Panniculitis etiology, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic diagnosis, Lupus Erythematosus, Systemic pathology
- Abstract
Introduction: Lupus erythematous panniculitis (LEP) is a rare type of chronic cutaneous lupus erythematous. Clinical characteristics are tender, subcutaneous nodules, erythematous plaques. Disfigurement of face and body might develop which affects the patient's quality of life. LEP can be the first sign of systemic lupus erythematous (SLE)., Objective: Our aim was to review the clinicopathological characteristics and the course of LEP through our own patients., Methods: We retrospectively analyzed the clinical records of 17 LEP patients at Semmelweis University's Department of Dermatology, Venerology and Dermatooncology between 2000 and 2022., Results: The male : female ratio was 1 : 16, average age was 37.8 years. Lesion localisations were proximal lower (8/17) and upper extremities (7/17), face (4/17), breast (3/17), chest (2/17), buttocks (2/17), back (1/17) and distal lower extremity (1/17). Lesion morphologies were nodules (11/17), plaques (7/17), lipoatrophy (4/17), ulceration (3/17), calcification (1/17). Discoid changes covered in 6 cases. In 10 cases, systemic symptoms were observed (arthritis (4/17), haematological (5/17), renal (2/17), anti-phospholipid syndrome (2/17). 7 patients fulfilled the EULAR/ACR criteria for SLE. Histology showed mixed type panniculitis in 8, lobular in 3 cases. Average time until diagnosis was 24.3 months. Among all our SLE patients, skin symptoms regressed following systemic immunosuppressive treatment. LEP patients with only skin manifestation were often resistant for the therapy of cutaneous lupus erythematous., Conclusion: The diagnosis of LEP often takes months or years. Wider knowledge of LEP would shorten the time to diagnosis, preventing disfigurement and possible damage of internal organs. Based on our observations, LEP without SLE might be treated with early immunosuppression. Orv Hetil. 2023; 164(5): 172-178.
- Published
- 2023
- Full Text
- View/download PDF
45. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021.
- Author
-
Abolhassani H, Avcin T, Bahceciler N, Balashov D, Bata Z, Bataneant M, Belevtsev M, Bernatowska E, Bidló J, Blazsó P, Boisson B, Bolkov M, Bondarenko A, Boyarchuk O, Bundschu A, Casanova JL, Chernishova L, Ciznar P, Csürke I, Erdős M, Farkas H, Fomina DS, Galal N, Goda V, Guner SN, Hauser P, Ilyina NI, Iremadze T, Iritsyan S, Ismaili-Jaha V, Jesenak M, Kelecic J, Keles S, Kindle G, Kondratenko IV, Kostyuchenko L, Kovzel E, Kriván G, Kuli-Lito G, Kumánovics G, Kurjane N, Latysheva EA, Latysheva TV, Lázár I, Markelj G, Markovic M, Maródi L, Mammadova V, Medvecz M, Miltner N, Mironska K, Modell F, Modell V, Mosdósi B, Mukhina AA, Murdjeva M, Műzes G, Nabieva U, Nasrullayeva G, Naumova E, Nagy K, Onozó B, Orozbekova B, Pac M, Pagava K, Pampura AN, Pasic S, Petrosyan M, Petrovic G, Pocek L, Prodeus AP, Reisli I, Ress K, Rezaei N, Rodina YA, Rumyantsev AG, Sciuca S, Sediva A, Serban M, Sharapova S, Shcherbina A, Sitkauskiene B, Snimshchikova I, Spahiu-Konjusha S, Szolnoky M, Szűcs G, Toplak N, Tóth B, Tsyvkina G, Tuzankina I, Vlasova E, and Volokha A
- Subjects
- Infant, Newborn, Humans, Administration, Intravenous, Educational Status, Egypt, Europe, Immunoglobulin G
- Abstract
Introduction: The J Project (JP) physician education and clinical research collaboration program was started in 2004 and includes by now 32 countries mostly in Eastern and Central Europe (ECE). Until the end of 2021, 344 inborn errors of immunity (IEI)-focused meetings were organized by the JP to raise awareness and facilitate the diagnosis and treatment of patients with IEI., Results: In this study, meeting profiles and major diagnostic and treatment parameters were studied. JP center leaders reported patients' data from 30 countries representing a total population of 506 567 565. Two countries reported patients from JP centers (Konya, Turkey and Cairo University, Egypt). Diagnostic criteria were based on the 2020 update of classification by the IUIS Expert Committee on IEI. The number of JP meetings increased from 6 per year in 2004 and 2005 to 44 and 63 in 2020 and 2021, respectively. The cumulative number of meetings per country varied from 1 to 59 in various countries reflecting partly but not entirely the population of the respective countries. Altogether, 24,879 patients were reported giving an average prevalence of 4.9. Most of the patients had predominantly antibody deficiency (46,32%) followed by patients with combined immunodeficiencies (14.3%). The percentages of patients with bone marrow failure and phenocopies of IEI were less than 1 each. The number of patients was remarkably higher that those reported to the ESID Registry in 13 countries. Immunoglobulin (IgG) substitution was provided to 7,572 patients (5,693 intravenously) and 1,480 patients received hematopoietic stem cell therapy (HSCT). Searching for basic diagnostic parameters revealed the availability of immunochemistry and flow cytometry in 27 and 28 countries, respectively, and targeted gene sequencing and new generation sequencing was available in 21 and 18 countries. The number of IEI centers and experts in the field were 260 and 690, respectively. We found high correlation between the number of IEI centers and patients treated with intravenous IgG (IVIG) (correlation coefficient, cc, 0,916) and with those who were treated with HSCT (cc, 0,905). Similar correlation was found when the number of experts was compared with those treated with HSCT. However, the number of patients treated with subcutaneous Ig (SCIG) only slightly correlated with the number of experts (cc, 0,489) and no correlation was found between the number of centers and patients on SCIG (cc, 0,174)., Conclusions: 1) this is the first study describing major diagnostic and treatment parameters of IEI care in countries of the JP; 2) the data suggest that the JP had tremendous impact on the development of IEI care in ECE; 3) our data help to define major future targets of JP activity in various countries; 4) we suggest that the number of IEI centers and IEI experts closely correlate to the most important treatment parameters; 5) we propose that specialist education among medical professionals plays pivotal role in increasing levels of diagnostics and adequate care of this vulnerable and still highly neglected patient population; 6) this study also provides the basis for further analysis of more specific aspects of IEI care including genetic diagnostics, disease specific prevalence, newborn screening and professional collaboration in JP countries., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Abolhassani, Avcin, Bahceciler, Balashov, Bata, Bataneant, Belevtsev, Bernatowska, Bidló, Blazsó, Boisson, Bolkov, Bondarenko, Boyarchuk, Bundschu, Casanova, Chernishova, Ciznar, Csürke, Erdős, Farkas, Fomina, Galal, Goda, Guner, Hauser, Ilyina, Iremadze, Iritsyan, Ismaili-Jaha, Jesenak, Kelecic, Keles, Kindle, Kondratenko, Kostyuchenko, Kovzel, Kriván, Kuli-Lito, Kumánovics, Kurjane, Latysheva, Latysheva, Lázár, Markelj, Markovic, Maródi, Mammadova, Medvecz, Miltner, Mironska, Modell, Modell, Mosdósi, Mukhina, Murdjeva, Műzes, Nabieva, Nasrullayeva, Naumova, Nagy, Onozó, Orozbekova, Pac, Pagava, Pampura, Pasic, Petrosyan, Petrovic, Pocek, Prodeus, Reisli, Ress, Rezaei, Rodina, Rumyantsev, Sciuca, Sediva, Serban, Sharapova, Shcherbina, Sitkauskiene, Snimshchikova, Spahiu-Konjusha, Szolnoky, Szűcs, Toplak, Tóth, Tsyvkina, Tuzankina, Vlasova and Volokha.)
- Published
- 2022
- Full Text
- View/download PDF
46. Assessment of the Genetic Spectrum of Uncombable Hair Syndrome in a Cohort of 107 Individuals.
- Author
-
Basmanav FB, Cesarato N, Kumar S, Borisov O, Kokordelis P, Ralser DJ, Wehner M, Axt D, Xiong X, Thiele H, Dolgin V, Gossmann Y, Fricker N, Dewenter MK, Weller K, Suri M, Reichenbach H, Oji V, Addor MC, Ramirez K, Stewart H, Garcia Bartels N, Weibel L, Wagner N, George S, Kilic A, Tantcheva-Poor I, Stewart A, Dikow N, Blaumeiser B, Medvecz M, Blume-Peytavi U, Farrant P, Grimalt R, Bertok S, Bradley L, Eskin-Schwartz M, Birk OS, Bygum A, Simon M, Krawitz P, Fischer C, Hamm H, Fritz G, and Betz RC
- Subjects
- Female, Male, Humans, Cohort Studies, Exome Sequencing, Hair abnormalities, Transglutaminases, Hair Diseases diagnosis, Hair Diseases genetics
- Abstract
Importance: Uncombable hair syndrome (UHS) is a rare hair shaft anomaly that manifests during infancy and is characterized by dry, frizzy, and wiry hair that cannot be combed flat. Only about 100 known cases have been reported so far., Objective: To elucidate the genetic spectrum of UHS., Design, Setting, and Participants: This cohort study includes 107 unrelated index patients with a suspected diagnosis of UHS and family members who were recruited worldwide from January 2013 to December 2021. Participants of all ages, races, and ethnicities were recruited at referral centers or were enrolled on their own initiative following personal contact with the authors. Genetic analyses were conducted in Germany from January 2014 to December 2021., Main Outcomes and Measures: Clinical photographs, Sanger or whole-exome sequencing and array-based genotyping of DNA extracted from blood or saliva samples, and 3-dimensional protein modeling. Descriptive statistics, such as frequency counts, were used to describe the distribution of identified pathogenic variants and genotypes., Results: The genetic characteristics of patients with UHS were established in 80 of 107 (74.8%) index patients (82 [76.6%] female) who carried biallelic pathogenic variants in PADI3, TGM3, or TCHH (ie, genes that encode functionally related hair shaft proteins). Molecular genetic findings from 11 of these 80 individuals were previously published. In 76 (71.0%) individuals, the UHS phenotype were associated with pathogenic variants in PADI3. The 2 most commonly observed PADI3 variants account for 73 (48.0%) and 57 (37.5%) of the 152 variant PADI3 alleles in total, respectively. Two individuals carried pathogenic variants in TGM3, and 2 others carried pathogenic variants in TCHH. Haplotype analyses suggested a founder effect for the 4 most commonly observed pathogenic variants in the PADI3 gene., Conclusions and Relevance: This cohort study extends and gives an overview of the genetic variant spectrum of UHS based on molecular genetic analyses of the largest worldwide collective of affected individuals, to our knowledge. Formerly, a diagnosis of UHS could only be made by physical examination of the patient and confirmed by microscopical examination of the hair shaft. The discovery of pathogenic variants in PADI3, TCHH, and TGM3 may open a new avenue for clinicians and affected individuals by introducing molecular diagnostics for UHS.
- Published
- 2022
- Full Text
- View/download PDF
47. Surprising genetic and pathological findings in a patient with giant bilateral periadrenal tumours: PEComas and mutations of PTCH1 in Gorlin-Goltz syndrome.
- Author
-
Igaz P, Toth G, Nagy P, Dezső K, Turai PI, Medvecz M, Wikonkal N, Huszty G, Piros L, Toth E, Bozsik A, Likó I, Patócs A, and Butz H
- Subjects
- Hedgehog Proteins genetics, Humans, Male, Mosaicism, Mutation, Young Adult, Basal Cell Nevus Syndrome genetics, Basal Cell Nevus Syndrome pathology, Patched-1 Receptor genetics, Perivascular Epithelioid Cell Neoplasms
- Abstract
Gorlin-Goltz syndrome (GGS) or nevoid basal cell carcinoma syndrome is a rare tumour-overgrowth syndrome associated with multiple developmental anomalies and a wide variety of tumours. Here, we describe a case of a man aged 23 years with GGS with bilateral giant tumours adjacent to both adrenals that raised the suspicion of malignancy on imaging. Histological analysis of both surgically resected tumours revealed perivascular epitheloid cell tumours (PEComas) that were independent of the adrenals. Exome sequencing of the patient's blood sample revealed a novel germline heterozygous frameshift mutation in the PTCH1 gene. As a second hit, a somatic five nucleotide long deletion in the PTCH1 gene was demonstrated in the tumour DNA of both PEComas. To the best of our knowledge, this is the first report on PEComa in GGS, and this finding also raises the potential relevance of PTCH1 mutations and altered sonic hedgehog signalling in PEComa pathogenesis. The presence of the same somatic mutation in the bilateral tumours might indicate the possibility of a postzygotic somatic mutation that along with the germline mutation of the same gene could represent an intriguing genetic phenomenon (type 2 segmental mosaicism)., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
48. Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus.
- Author
-
Király Z, Szepesi Á, Sebestyén A, Kuroli E, Rencz F, Tóth B, Bokor L, Szakonyi J, Medvecz M, and Hidvégi B
- Subjects
- B7-H1 Antigen metabolism, Granzymes metabolism, Humans, Programmed Cell Death 1 Receptor metabolism, Skin pathology, Lupus Erythematosus, Cutaneous metabolism, Lupus Erythematosus, Cutaneous pathology, Lupus Erythematosus, Discoid metabolism, Lupus Erythematosus, Discoid pathology
- Abstract
The pathomechanism of various autoimmune diseases is known to be associated with the altered function of programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) axis. We aimed to investigate the role of this pathway and inflammatory cell markers in subtypes of cutaneous lupus erythematosus (CLE): discoid lupus erythematosus (DLE), subacute CLE (SCLE) and toxic epidermal necrolysis (TEN)-like lupus, a hyperacute form of acute CLE (ACLE). Ten skin biopsy samples from 9 patients were analyzed with immunohistochemistry regarding the following markers: CD3, CD4, CD8, Granzyme B, CD123, CD163, PD-1, PD-L1. Our group consisted of 4 SCLE (2 idiopathic (I-SCLE) and 2 PD-1 inhibitor-induced (DI-SCLE)), 4 DLE and 1 TEN-like lupus cases. From the latter patient two consecutive biopsies were obtained 1 week apart. Marker expression patterns were compared through descriptive analysis. Higher median keratinocyte (KC) PD-L1 expression was observed in the SCLE group compared to the DLE group (65% and 5%, respectively). Medians of dermal CD4, Granzyme B (GB), PD-1 positive cell numbers and GB+/CD8
+ ratio were higher in the DLE group than in the SCLE group. The I-SCLE and DI-SCLE cases showed many similarities, however KC PD-L1 expression and dermal GB positive cell number was higher in the former. The consecutive samples of the TEN-like lupus patient showed an increase by time within the number of infiltrating GB+ cytotoxic T-cells and KC PD-L1 expression (from 22 to 43 and 30%-70%, respectively). Alterations of the PD-1/PD-L1 axis seems to play a role in the pathogenesis of CLE., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Király, Szepesi, Sebestyén, Kuroli, Rencz, Tóth, Bokor, Szakonyi, Medvecz and Hidvégi.)- Published
- 2022
- Full Text
- View/download PDF
49. Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals-Prospective observational cohort study.
- Author
-
Piros ÉA, Cseprekál O, Görög A, Hidvégi B, Medvecz M, Szabó Z, Olajos F, Barabás E, Galajda N, Miheller P, and Holló P
- Subjects
- 2019-nCoV Vaccine mRNA-1273, Adult, Aged, BNT162 Vaccine, COVID-19 Vaccines adverse effects, Humans, Middle Aged, Prospective Studies, RNA, Messenger, SARS-CoV-2, Seroconversion, Vaccination adverse effects, Biological Products adverse effects, COVID-19 prevention & control
- Abstract
It is unclear whether biological antipsoriatic therapies affect seroconversion after messenger ribonucleic acid (mRNA)-based antisevere acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) vaccinations. To assess antibody formation and the incidence of side effects after anti-SARS-CoV-2 mRNA vaccinations in psoriatic patients receiving different biologicals compared to healthy controls. 102 moderate-to-severe psoriatic patients (56.2 [±13.5] years) and 55 age-matched healthy (56.4 ± 13.6 years) volunteers were included in our study. Ten to 21 days after the administration of the second dosage of BNT162b2 or mRNA-1273 vaccine, antibody levels specific to the SARS-CoV-2 spike (S) protein receptor binding domain were monitored. The incidence of postvaccination side effects was recorded and compared to real-life data in the literature. Of the 102 patients, 57 (55.88%) received tumor necrosis factor (TNF), 28 (27.45%) received interleukin (IL)-12/23, 16 (15.68%) received IL-17, and 1 (0.99%) received IL-23 inhibitors. No significant differences in the median serum level of anti-SARS-CoV-2S antibody were observed between the study population and the control group (median IQR range: 1681.0 U/mL (600.0-4844.0) versus 1984.0 U/mL (1000.0-3136.0; p = 0.82). The most frequent side effects of the mRNA vaccines within 7 days after the administration of both dosages were arm pain on the side of injection (23.53% and 23.53%), fatigue (9.80% and 13.72%), headache (4.9% and 5.88%), and chills or shivering (4.9% and 8.82%). Detectable antibodies against SARS-CoV-2S protein appear 10-21 days after the administration of the second dosage of BNT162b2 or mRNA-1273 vaccines in moderate-to-severe psoriatic patients receiving biologicals, similar to those of healthy controls., (© 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
50. Multidisciplinary management of patients affected with pseudoxanthoma elasticum
- Author
-
Farkas K, Kiss N, Szabó V, Resch M, Vámos R, Borbándy Á, Nagy A, Apor A, Arányi T, Szeri F, Wikonkál N, Nagy Z, Merkely B, and Medvecz M
- Subjects
- Bruch Membrane, Humans, Mutation, Phenotype, Skin pathology, Pseudoxanthoma Elasticum diagnosis, Pseudoxanthoma Elasticum genetics
- Abstract
Pseudoxanthoma elasticum (PXE, OMIM # 264800) is an autosomal recessive, multisystemic disorder, associated with mutations of the ABCC6 gene. Ectopic mineralization is in the background of the clinical manifestations of the disease. Calcium-salt crystals are deposited primarily in the skin, in the Bruch membrane of the eyes, and in the vascular endothelium. Thus, in addition to the skin lesions, visual impairment and cardiovascular involvement also occur. Clinical symptoms show varying severity and display heterogeneous appearance. The identification of the phenotype and care of the patients require a multidisciplinary perspective based on the collaboration of a dermatologist, ophthalmologist, cardiologist, and clinical geneticist. The aim of our work is to describe the development of symptoms of the disease, in order to facilitate the diagnosis. In addition, we aim to draw attention to the importance of early diagnosis of pseudoxanthoma elasticum, and to present modern diagnostic methods. Considering the development of severe systemic complications, the early diagnosis with the collaboration between related specialists is crucial to provide optimal clinical care and management of the patients.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.